Century Therapeutics Ownership | Who Owns Century Therapeutics?


OverviewForecastRevenueFinancialsChart

Century Therapeutics Ownership Summary


Century Therapeutics is owned by 46.81% institutional investors, 28.36% insiders, and 24.84% retail investors. Bain capital life sciences investors is the largest institutional shareholder, holding 8.68% of IPSC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.55% of its assets in Century Therapeutics shares.

IPSC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCentury Therapeutics46.81%28.36%24.84%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bain capital life sciences investors5.41M8.68%$13.80M
Vr adviser5.39M8.65%$13.74M
Casdin capital5.19M8.33%$13.24M
Boxer capital4.90M7.87%$12.50M
Fmr2.95M4.74%$7.52M
Blackrock2.90M4.65%$7.38M
Vanguard group1.73M2.78%$4.42M
Dafna capital management1.70M2.74%$4.35M
Octagon capital advisors lp1.33M2.14%$3.40M
Adage capital partners gp1.32M2.12%$3.37M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Syncona portfolio1.00M2.97%$2.55M
Bain capital life sciences investors5.41M1.51%$13.80M
Dafna capital management1.70M1.04%$4.35M
Casdin capital5.19M1.01%$13.24M
Vr adviser5.39M0.88%$13.74M
Boxer capital4.90M0.66%$12.50M
Octagon capital advisors lp1.33M0.53%$3.40M
Tang capital management900.00K0.23%$2.29M
Parametrica management27.84K0.09%$70.99K
Harbourvest partners29.02K0.04%$74.00K

Top Buyers

HolderShares% AssetsChange
Bain capital life sciences investors5.41M1.51%5.41M
Boxer capital4.90M0.66%3.15M
Casdin capital5.19M1.01%1.98M
Vr adviser5.39M0.88%1.98M
Blackrock2.90M0.00%1.40M

Top Sellers

HolderShares% AssetsChange
Avidity partners management lp---1.22M
Fmr2.95M0.00%-420.95K
Jacobs levy equity management10.58K0.00%-283.36K
Federated hermes---276.16K
Schonfeld strategic advisors---93.08K

New Positions

HolderShares% AssetsChangeValue
Bain capital life sciences investors5.41M1.51%5.41M$13.80M
Adage capital partners gp1.32M0.01%1.32M$3.37M
Syncona portfolio1.00M2.97%1.00M$2.55M
Corebridge financial24.68K0.00%24.68K$62.94K
Voya investment management17.44K0.00%17.44K$44.46K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-6.00
Qube research-334.00
Simplex trading-2.42K
Comerica bank-2.95K
Point72 (difc)-6.43K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20246811.48%39,649,236-1.17%461.96%31-20.51%1633.33%
Jun 30, 202460-10.45%40,117,75873.62%644.24%3939.29%11-50.00%
Mar 31, 2024676.35%23,106,28030.72%384.41%28-17.65%2210.00%
Dec 31, 20236314.55%17,675,612-2.13%293.20%3470.00%20-
Sep 30, 202355-15.38%18,061,121-6.38%302.81%20-16.67%20-16.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.31M1.55%-
Fidelity Growth Compy Commingled Pl S1.23M1.46%9.52K
Fidelity Growth Compy Commingled Pl O1.22M1.45%-96.60K
iShares Russell 2000 ETF1.03M1.21%-2.31K
Syncona Ord1.00M1.18%1.00M
Vanguard Institutional Extnd Mkt Idx Tr785.57K0.93%-
Fidelity Growth Company Fund746.17K0.88%-1.58K
Fidelity Small Cap Index477.39K0.56%-841.00
Fidelity Growth Company K6459.69K0.54%-7.93K
iShares Russell 2000 Value ETF418.22K0.49%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 04, 2024Farid Adrienne Chief Operations OfficerSell$1.27K
Nov 04, 2024Carr Douglas SVP Finance & OperationsSell$347.24
Sep 12, 2024Quimi Daphne-Buy$7.66K
Aug 05, 2024Farid Adrienne Chief Operations OfficerSell$1.96K
Aug 05, 2024Carr Douglas SVP Finance & OperationsSell$528.00

Insider Transactions Trends


DateBuySell
2024 Q4-2
2024 Q315
2024 Q2-7
2024 Q1-7
2023 Q4--

IPSC Ownership FAQ


Who Owns Century Therapeutics?

Century Therapeutics shareholders are primarily institutional investors at 46.81%, followed by 28.36% insiders and 24.83% retail investors. The average institutional ownership in Century Therapeutics's industry, Biotech Stocks , is 44.97%, which Century Therapeutics exceeds.

Who owns the most shares of Century Therapeutics?

Century Therapeutics’s largest shareholders are Bain capital life sciences investors (5.41M shares, 8.68%), Vr adviser (5.39M shares, 8.65%), and Casdin capital (5.19M shares, 8.33%). Together, they hold 25.67% of Century Therapeutics’s total shares outstanding.

Does Blackrock own Century Therapeutics?

Yes, BlackRock owns 4.65% of Century Therapeutics, totaling 2.9M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.38M$. In the last quarter, BlackRock increased its holdings by 1.4M shares, a 93.28% change.

Who is Century Therapeutics’s biggest shareholder by percentage of total assets invested?

Syncona portfolio is Century Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.97% of its assets in 1M Century Therapeutics shares, valued at 2.55M$.

Who is the top mutual fund holder of Century Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Century Therapeutics shares, with 1.55% of its total shares outstanding invested in 1.31M Century Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools